Leerink Partners downgraded ARMO BioSciences, Inc. (NASDAQ: ARMO) from Outperform ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Downgrades

Baird Downgrades ARMO BioSciences, Inc. (ARMO) to Neutral Following Acquisition May 10, 2018 12:27 PM BMO Capital Downgrades ARMO BioSciences, Inc. (ARMO) to Market Perform Following TakeoverMay 10, 2018 11:03 AM